Glaucoma risk can be managed more effectively with the ability to use polygenic risk scores to identify individuals who can ...

And rates are estimated to be even higher by 2033, plus educating caregiver of aging adults on retinal disease and ...

Migraine may be a significant risk factor for the likelihood of the development of open-angle glaucoma, a Korean population study shows.

For patients with African ancestry, low body mass index may be a risk factor for increased primary open-angle glaucoma. Among people with African ancestry, body mass index lower than 18.5 (low BMI) is ...

Sight Sciences’ management is scheduled to present on Tuesday, December 3, 2024, at 12:30 pm PT / 3:30 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the ...

Press Release Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 TrialAn adaptive design is a useful ...

Globally, glaucoma is the leading cause of blindness and vision loss, and it has a significant impact on quality of life (Fujiwara et al., 2022) Glaucoma is categorized as primary open-angle glaucoma ...

SpyGlass Pharma Inc. has developed an intraocular lens (IOL) capable of continuously delivering drugs to eyes for up to three ...

A study published in the American Journal of Ophthalmology suggests that the use of SGLT2 inhibitors in diabetes is linked to ...

According to a new comprehensive report from The Insight Partners, the global Glaucoma Therapeutics Market is experiencing significant growth owing to ...

The beta blockers segment held the largest share of the market in 2023. In terms of indication, the glaucoma therapeutics market is segmented into open-angle glaucoma, angle closure glaucoma, and ...